What is the treatment for hyperemesis (hyperemesis gravidarum) due to cannabis use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The most effective treatment for hyperemesis due to cannabis, also known as Cannabinoid Hyperemesis Syndrome (CHS), is complete cessation of cannabis use, which typically resolves symptoms within 24-48 hours. This approach is supported by recent clinical practice updates, such as the one published in Gastroenterology in 2024 1. For immediate symptom relief, hot showers or baths can provide temporary comfort due to the effect of heat on cannabinoid receptors.

Management of Symptoms

Medications that can help manage symptoms include:

  • Ondansetron (Zofran) 4-8mg every 8 hours
  • Promethazine (Phenergan) 12.5-25mg every 6 hours
  • Metoclopramide (Reglan) 10mg every 6 hours for nausea and vomiting Intravenous fluids may be necessary for dehydration. Topical capsaicin cream applied to the abdomen can also help by affecting the same receptors activated during hot showers, as suggested by a recent study in 2024 1.

Additional Therapies

Benzodiazepines like lorazepam (1-2mg) can reduce anxiety and help with symptoms. Proton pump inhibitors such as omeprazole (20-40mg daily) may alleviate associated gastric discomfort. For severe cases, haloperidol (0.5-2mg) has shown effectiveness. It's crucial for patients to understand that symptoms will likely return if cannabis use resumes, as CHS results from chronic cannabis exposure affecting the endocannabinoid system's regulation of nausea and vomiting. Long-term management may involve counseling to achieve marijuana cessation and the use of tricyclic antidepressants, such as amitriptyline, with the minimal effective dose being 75–100 mg at bedtime 1.

From the Research

Treatment Options for Hyperemesis due to Cannabis

  • The treatment of hyperemesis due to cannabis, also known as cannabinoid hyperemesis syndrome (CHS), is a complex issue, and various studies have investigated different treatment options 2, 3, 4, 5, 6.
  • According to the studies, the following treatment options have been found to be effective:
    • Haloperidol: an antipsychotic that has been shown to be more effective than conventional antiemetics for symptom control 4, 5, 6.
    • Lorazepam: a benzodiazepine that has been used in combination with haloperidol for acute treatment of CHS 5.
    • Capsaicin: a topical cream that has been found to be effective in alleviating symptoms of CHS, with a low adverse-effect profile 3, 5, 6.
    • Hydrothermotherapy (hot showers and baths): has been reported to provide relief from symptoms of CHS 2, 3, 6.

Comparison of Treatment Options

  • A randomized controlled trial compared haloperidol with ondansetron for the treatment of CHS and found that haloperidol was superior to ondansetron in alleviating acute symptoms 4.
  • Another study found that haloperidol, lorazepam, and/or capsaicin were effective in treating adolescent patients with CHS 5.
  • A review of the presentation and treatment of CHS found that antipsychotics such as haloperidol or droperidol were more effective than conventional antiemetics for symptom control, and that capsaicin should also be considered due to its positive efficacy and low adverse-effect profile 6.

Limitations and Future Research

  • The studies highlight the need for further research to elicit the exact mechanism of CHS and to develop additional therapies for this syndrome 3, 6.
  • The current evidence for pharmacologic treatment of CHS is limited, and more prospective trials are needed to evaluate and define optimal pharmacologic treatment of patients with CHS 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.